UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 82 filers reported holding UNITY BIOTECHNOLOGY INC in Q3 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $625,000 | +15.7% | 1,582,369 | +65.2% | 0.00% | 0.0% |
| Q2 2022 | $540,000 | -46.9% | 957,718 | +5.6% | 0.00% | 0.0% |
| Q1 2022 | $1,016,000 | -35.4% | 906,715 | -15.9% | 0.00% | -50.0% |
| Q4 2021 | $1,573,000 | -18.2% | 1,077,700 | +68.2% | 0.00% | 0.0% |
| Q3 2021 | $1,922,000 | -19.2% | 640,700 | +25.0% | 0.00% | -33.3% |
| Q2 2021 | $2,378,000 | -2.5% | 512,600 | +82.5% | 0.00% | +50.0% |
| Q2 2020 | $2,438,000 | +190.9% | 280,900 | +94.5% | 0.00% | +100.0% |
| Q1 2020 | $838,000 | +288.0% | 144,400 | +381.3% | 0.00% | – |
| Q4 2019 | $216,000 | – | 30,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mayo Clinic | 1,571,981 | $8,237,000 | 9.91% |
| Invus Financial Advisors, LLC | 1,094,998 | $5,738,000 | 2.40% |
| Founders Fund V Management, LLC | 491,751 | $2,577,000 | 0.66% |
| ALGERT GLOBAL LLC | 51,890 | $272,000 | 0.08% |
| Arbor Wealth Management, LLC | 25,888 | $136,000 | 0.05% |
| Moloney Securities Asset Management, LLC | 41,950 | $220,000 | 0.05% |
| PDT Partners, LLC | 78,800 | $413,000 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 394,957 | $2,070,000 | 0.02% |
| Fort Point Capital Partners LLC | 10,000 | $52,000 | 0.01% |
| Baillie Gifford | 3,803,014 | $19,928,000 | 0.01% |